Table 2.
Plasma | myristic (mmol/l) |
palmitic (mmol/l) |
palmitoleic (mmol/l) |
stearic (mmol/l) |
oleic (mmol/l) |
linoeate (mmol/l) |
γ-linolenic (mmol/l) |
α-linolenic (mmol/l) |
arachidonic (mmol/l) |
---|---|---|---|---|---|---|---|---|---|
Pre-fenofibrate | |||||||||
Men | 0.12±0.02* | 1.04±0.08 | 0.12±0.01 | 0.40±0.04* | 1.19±0.07 | 1.01±0.10 | 0.03±0.00 | 0.07±0.01 | 0.11±0.01* |
Women | 0.06±0.01 | 0.83±0.12 | 0.13±0.03 | 0.27±0.03 | 1.11±0.19 | 0.91±0.11 | 0.02±0.00 | 0.07±0.01 | 0.08±0.01 |
Post-fenofibrate | |||||||||
Men | 0.07±0.01 | 0.79±0.09 | 0.11±0.02 | 0.27±0.05 | 0.90±0.07 | 0.66±0.05 | 0.03±0.00 | 0.04±0.01 | 0.11±0.01 |
Women | 0.04±0.01 | 0.63±0.10 | 0.11±0.02 | 0.20±0.03 | 0.86±0.15 | 0.62±0.12 | 0.02±0.00 | 0.04±0.01 | 0.09±0.01 |
Muscle |
myristic (ug/mg dry wt) |
palmitic (ug/mg dry wt) |
palmitoleic (ug/mg dry wt) |
stearic (ug/mg dry wt) |
oleic (ug/mg dry wt) |
linoeate (ug/mg dry wt) |
linolenic (ug/mg dry wt) |
arachidonic (ug/mg dry wt) |
|
Pre-fenofibrate | |||||||||
Men | 1.84±0.21 | 24.19±0.62 | 4.51±0.57 | 9.14±1.52 | 33.56±3.29* | 16.13±0.33 | 0.84±0.05 | 0.85±0.11 | |
Women | 2.24±0.16 | 23.88±0.86 | 5.00±0.35 | 6.23±0.59 | 45.89±1.68 | 15.21±0.40 | 0.86±0.05 | 0.68±0.10 | |
Post-fenofibrate | |||||||||
Men | 2.23±0.20 | 25.46±0.69* | 3.40±0.31* | 9.35±1.03* | 42.19±1.36* | 15.02±0.06 | 0.91±0.04 | 0.89±0.08 | |
Women | 1.78±0.31 | 21.62±1.62 | 5.25±0.74 | 5.26±1.24 | 49.40±2.39 | 14.89±0.05 | 0.85±0.04 | 0.73±0.09 |
p<0.05 men vs. women
p<0.05 pre- vs. post-fenofbrate
wt = weight